The Phase I trial will study target dose levels of 5 mg/kg, 10 mg/kg and 20 mg/kg of PGN-EDODM1, with safety, transcript splicing and clinical outcome measures data from the 5 mg/kg cohort expected in 2024
Suzette Glasner Podcast here: She also reviews findings from large-scale studies involving tens of thousands of individuals, showing significantly lower rates of alcohol use disorder and relapse among people taking medications like semaglutide, along with emerging evidence across other substances
established a synergistic therapeutic strategy based on a thermosensitive in situ hydrogel consisting of poloxamer and hyaluronic acid, which allows the co-delivery of Fer-1 and antifungal agents
By charting the types of interventions studied, outcomes assessed, and the main areas of research concentration and scarcity, this review provides a descriptive overview of the field and informs future research directions, thereby supporting clinicians, researchers, and policymakers in developing more evidence-informed approaches to improving care and quality of life for individuals undergoing long-term hemodialysis
Especially in higher stages of lipedema, there is an increased risk of venous thromboembolism (blood clot) and pulmonary embolus ( blood clot to lung) after surgery
A 2018 systematic review and meta-analysis identified 20 randomized controlled trials (published between 2007 and 2017) that examined the effect of supplemental lipoic acid on markers of glucose utilization in 1,245 subjects with metabolic disorders (not limited to type 2 diabetes) (60)
